Our
Story

Biobrás and Eli Lilly & Co (USA) form a joint venture, which is a pioneer in insulin production in Brazil.
Learn More
 
Timeline
1975
PRODUCTION PIONEERS IN BRAZIL INSULIN
Biobrás and Eli Lilly & Co (USA) form a joint venture, which is a pioneer in insulin production in Brazil.
Insulin crystals are produced in Montes Claros and marketed worldwide. The Biobrás is inspected and approved by the US FDA
1979
PRODUCTION PIONEERS IN BRAZIL INSULIN
Biobrás and Eli Lilly & Co (USA) form a joint venture, which is a pioneer in insulin production in Brazil.
Insulin crystals are produced in Montes Claros and marketed worldwide. The Biobrás is inspected and approved by the US FDA
1983
PRODUCTION AND FORMULATION OF HIGHLY PURIFIED INSULINS
Development of highly purified insulins and formulation of injectable insulin, i.e. ready to be used. 4A. LARGEST INTEGRATED INSULIN PRODUCER IN THE WORLD Biobrás conquers new markets, diversifying its product line. Herewith, it became the 4th largest insulin producer in the world and the largest in Latin America, selling to over 25 countries a complete line of drugs in cardiology and endocrinology.
LATE 90’S
HUMAN RECOMBINANT INSULIN
Biobrás concludes its technological development in recombinant human insulin production. After taking all manufacturing processes to an industrial scale, the first patent was obtained in 2000.
2001
BIOMM FOUNDATION
Biobrás is split and part of it is named Biomm, into which is transferred all the intellectual property, know-how, researchers and executives who made Biobrás the fourth largest producer of insulin in the world.
2002
SALES OF CORPORATE CONTROL OF BIOBRÁS
 The shareholder control of Biobrás was sold to Novo Nordisk, having Biomm remained under control of the same entrepreneurs who in 1975 had the vision of mastering biotechnology.
This group led the development of biotechnology applied to health in Brazil.
Today
NEW BUSINESSES
 All Biomm technology produced on national soil is available for patent licensing to companies interested in insulin production.
Today, Biomm is a pioneer in processes and production of biotechnological products for industrial applications, with more than 30 years of experience in biotechnology and high investments in new markets and technological development.
Thus, the company integrates a network of innovation with the vast experience of institutions in Brazil and worldwide.
In addition, the company seeks partnerships to include more innovative products.